Navigation Links
Bond Laboratories Selects Wasserman Media Group
Date:11/28/2007


Global Sports and Entertainment Company to Market Fusion(TM) Instant Energy

Brands SOLANA BEACH, Calif. and CARLSBAD, Calif., Nov. 28 /PRNewswire-FirstCall/ -- Bond Laboratories, Inc. (OTC Bulletin Board: BNDB), a manufacturer of Fusion(TM) Blast and Fusion(TM) Shots nutritional energy products, has appointed Wasserman Media Group (WMG), to manage global marketing opportunities for its entire line of Fusion(TM) Instant Energy products. Through the agreement, WMG will work to partner Fusion(TM) with appropriate high profile athletes, promotions and feature Fusion(TM) at select large-scale events.

Eric Schick, President of Bond Laboratories, commented, "This partnership represents a vital step in the growth and development and of the Fusion(TM) brand nationally. WMG has a proven track record of consulting, endorsement and sponsorship programs for prominent sports and entertainment properties as well as consumer brands. Aligning ourselves with a company as dynamic as WMG will bring all Fusion(TM) products high visibility within the sports and entertainment event sectors."

Steve Astephen, Principal of Action Sports at WMG stated, "We are excited to be working with a company who embraces what sports and entertainment can do for their brand. We look forward to putting together cutting-edge programs that will help to elevate their brand to the next level."

About Bond Laboratories:

Bond Laboratories is a premier marketer and manufacturer of nationally branded nutritional products. Bond has brought together a seasoned team of highly successful sales and marketing executives with considerable experience in the launch and development of many well known branded products. With our previous nutraceutical and pharmaceutical sales and management expertise, Bond Laboratories, Inc. is currently focused on developing proprietary products, as well as delivery platforms, that address the needs and concerns of today's consumer. For more information on Fusion(TM) Products, interested persons can go to http://www.got-fusion.com.

About Wasserman Media Group

Wasserman Media Group (WMG) is a worldwide leader in sports management, marketing and content. WMG is also the holding company for the Los Angeles Avengers of the Arena Football League. More information about WMG and its businesses is available at http://www.wmgllc.com.

Wasserman Media Group, LLC (http://www.wmgllc.com) is also a leading global sports and Entertainment Company, and its Management, Marketing and Content divisions collectively represent the industries' most recognized athletes and brands. As the number one sports talent agency in basketball, baseball, soccer and action sports, WMG Management represents over 400 clients throughout the world. Recognized as the foremost naming rights expert, WMG Marketing also handles consulting, endorsement and sponsorship programs for the world's most prominent sports and entertainment properties and consumer brands.

Safe Harbor

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward- looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward- looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

Contact: Scott Landow Phone: 858.847.9000

sdlandow@bond-labs.com Fax: 858.847.9090


'/>"/>
SOURCE Bond Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
5. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
6. Andrew Lessmans TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System
7. Mesa Laboratories Names New Vice President of Sales and Marketing
8. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
9. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
10. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
11. JDRF partners with Housey Pharmaceutical Research Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... The bar ... glitterati, those unreal icons inhabiting the rarified air of pop and film stardom.(1) Not ... and anyone snapping pictures: the smile. Grins now run the gamut from being encrusted ...
(Date:4/24/2017)... ... 24, 2017 , ... Sean Fay is the undisputed king of the infomercial. ... and the George Foreman Grill (which sold more than 100 million units worldwide), he ... years. , Now, due to changes in the broadcast media landscape, the once ever-present ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP ... food supplements, announced its popular products are now available for purchase on StackedNutrition.com, ... prioritizes the use of premium natural ingredients in making all of its products. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Salus Telehealth, ... the company’s VideoMedicine mobile platform has launched Quick Care, a new service offering ... Quick Care provides patients with the option to request and begin a consultation ...
(Date:4/24/2017)... CA (PRWEB) , ... April 24, 2017 , ... ... brain tumors are expected to be diagnosed globally; approximately 25,000 of them will ... are anticipating greater use of this type of healthcare model in the diagnosis ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
(Date:4/19/2017)... 19, 2017  SARES•REGIS Group leased the first ... at Conejo Spectrum Business Park in ... Biotherapeutics, Inc. , a biopharmaceutical company developing meaningful ... that have been underserved by scientific innovation, with ... cancer, autoimmune and infectious disease. Before ...
Breaking Medicine Technology: